Top Markets
Coin of the day
Monterey Bio Acquisition Corporation Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRY
Classificação em ações #19499
Monterey Bio Acquisition Corporation currently lacks substantial operational... Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
Preço da ação
$11.14
Última sincronização: 2023-11-28
Valor de mercado
$160.14M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Monterey Bio Acquisition Corporation (MTRY)
EPS de Monterey Bio Acquisition Corporation (MTRY)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Monterey Bio Acquisition Corporation, o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Monterey Bio Acquisition Corporation de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes